Correlation Between Tarsus Pharmaceuticals and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Artiva Biotherapeutics,.
Diversification Opportunities for Tarsus Pharmaceuticals and Artiva Biotherapeutics,
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tarsus and Artiva is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Artiva Biotherapeutics,
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.66 times more return on investment than Artiva Biotherapeutics,. However, Tarsus Pharmaceuticals is 1.51 times less risky than Artiva Biotherapeutics,. It trades about 0.12 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 2,016 in Tarsus Pharmaceuticals on September 20, 2024 and sell it today you would earn a total of 3,310 from holding Tarsus Pharmaceuticals or generate 164.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 43.15% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Artiva Biotherapeutics, |
Tarsus Pharmaceuticals and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Artiva Biotherapeutics,
The main advantage of trading using opposite Tarsus Pharmaceuticals and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| Tarsus Pharmaceuticals vs. Emergent Biosolutions | Tarsus Pharmaceuticals vs. Neurocrine Biosciences | Tarsus Pharmaceuticals vs. Teva Pharma Industries | Tarsus Pharmaceuticals vs. Haleon plc |
| Artiva Biotherapeutics, vs. Paltalk | Artiva Biotherapeutics, vs. SEI Investments | Artiva Biotherapeutics, vs. GAMCO Global Gold | Artiva Biotherapeutics, vs. Royalty Management Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |